Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral Stem Cells in Bone Marrow Transplantation. Future prospects.

C H Hui1, L B To

  • 1Hanson Center for Cancer Research, Institute of Medical & Veterinary Sciences, Adelaide SA, Australia.

Bailliere'S Best Practice & Research. Clinical Haematology
|September 23, 2000
PubMed
Summary

Mobilized peripheral blood stem cells are now the primary source for transplantation. Advances in mobilization protocols enhance progenitor cell yield, improving high-dose therapy (HDT) safety and effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.

Leukemia·2017
Same author

Clinical outcome of HIV-infected haemophiliac patients in Hong Kong.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.

Bone marrow transplantation·2015
Same author

A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone.

Leukemia·2015
Same author

Relapsed multiple myeloma: who benefits from salvage autografts?

Internal medicine journal·2012
Same author

When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload?

Internal medicine journal·2012

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Mobilized peripheral blood cells are increasingly utilized as the primary source for hematopoietic progenitor cells in both autologous and allogeneic transplantation.
  • High-dose therapy (HDT) with peripheral blood stem cells offers superior engraftment kinetics, enhancing safety and cost-effectiveness.

Purpose of the Study:

  • To highlight the significance of mobilized peripheral blood cells in transplantation.
  • To discuss the impact of advances in mobilization protocols on progenitor cell yield and therapeutic strategies.
  • To explore the role of peripheral blood stem cell transplantation in improving tumor control and future therapeutic approaches.

Main Methods:

  • Review of current literature on peripheral blood stem cell mobilization and transplantation.

Related Experiment Videos

  • Analysis of the benefits of high-dose therapy (HDT) and advances in mobilization protocols.
  • Discussion of technological advancements in ex vivo expansion and manipulation of hematopoietic progenitor cell grafts.

    • Main Results:

    • Mobilized peripheral blood cells are the predominant source for hematopoietic progenitor cells.
    • Improved mobilization protocols ensure adequate and predictable progenitor cell yields.
    • Peripheral blood stem cell transplantation facilitates dose escalation, purging strategies, and immunomodulatory approaches for enhanced tumor control.

    Conclusions:

    • Peripheral blood stem cell transplantation is a cornerstone of modern cancer therapy, enabling dose escalation and improved treatment outcomes.
    • Advancements in mobilization and ex vivo manipulation techniques are expanding the therapeutic potential of peripheral blood stem cell transplantation.
    • The integration of technological innovations promises to broaden the application and efficacy of this transplantation method.